Late-onset RP has also been studied using the ROs from patients with PDE6B gene mutations, which decipher the underlying mechanisms of RP and evaluate new therapies overcoming interspecies variability due to using animal models [102]. This evidence concerns the gene PDE6B and retinitis pigmentosa 1.